DNA Virus Infections  >>  Pegasys (pegylated interferon α -2a)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT01734018: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Completed
N/A
50
Europe
Hoffmann-La Roche
Hepatitis B, Chronic
08/12
08/12
NCT01645969: A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265

Completed
N/A
65
RoW
Hoffmann-La Roche
Hepatitis B, Chronic
10/12
10/12
NCT01283074: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)

Completed
N/A
107
Europe
Hoffmann-La Roche
Hepatitis B, Chronic
11/12
11/12
NCT01705704: A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Completed
N/A
269
Europe, RoW
Hoffmann-La Roche
Hepatitis B, Chronic
02/13
02/13
NCT01886300: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

Terminated
N/A
16
RoW
Hoffmann-La Roche
Hepatitis B, Chronic
05/13
05/13
NCT01794234: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Terminated
N/A
44
Europe
Hoffmann-La Roche
Hepatitis B, Chronic
09/13
09/13
NCT01667432: An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Completed
N/A
141
Europe
Peginterferon alfa-2a, PEGASYS®, RO0258310
Hoffmann-La Roche
Hepatitis B, Chronic
08/14
08/14
NCT01011738: An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Completed
N/A
1842
Europe, RoW
Hoffmann-La Roche
Hepatitis B, Chronic
11/14
11/14
NCT01855997 / 2013-001141-14: A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue

Completed
N/A
1669
Europe, RoW
Peg-IFN alfa-2a, Pegasys
Hoffmann-La Roche
Hepatitis B, Chronic
11/14
11/14
NCT02201407: An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study

Completed
N/A
50
RoW
Peginterferon alfa-2a, PEGASYS
Hoffmann-La Roche
Hepatitis B, Chronic
04/17
04/17
NCT01730508: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Completed
N/A
978
RoW
Pegylated Interferon Alfa (Peginterferon Alfa), Pegasys
Hoffmann-La Roche
Hepatitis B, Chronic
06/17
06/17

Download Options